Literature DB >> 14996827

The generation of T cell memory: a review describing the molecular and cellular events following OX40 (CD134) engagement.

Andrew D Weinberg1, Dean E Evans, Colin Thalhofer, Tom Shi, Rodney A Prell.   

Abstract

OX40 (CD134), a membrane-bound member of the tumor necrosis factor-receptor superfamily, is expressed primarily on activated CD4(+) T cells. Following engagement on the cell surface, OX40 delivers a costimulatory signal that leads to potent, proinflammatory effects. Engagement of OX40 during antigen (Ag)-specific stimulation of T cells leads to increased production of memory T cells, increased migration of Ag-specific T cells, enhanced cytokine production by effector T cells, and the ability to break peripheral T cell tolerance in vivo. Therefore, OX40 engagement in vivo could have important ramifications for the enhancement of vaccine strategies and inhibition of unwanted inflammation. This review summarizes the molecular and cellular events that occur following OX40 engagement during Ag-specific T cell activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14996827     DOI: 10.1189/jlb.1103586

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  19 in total

Review 1.  The potential of CD4 T-cell memory.

Authors:  K Kai McKinstry; Tara M Strutt; Susan L Swain
Journal:  Immunology       Date:  2010-03-16       Impact factor: 7.397

2.  Activation-associated phenotype of CD3 T cells in acute graft-versus-host disease.

Authors:  M Paz Morante; J Briones; E Canto; H Sabzevari; R Martino; J Sierra; J L Rodriguez-Sanchez; S Vidal
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

Review 3.  The effector to memory transition of CD4 T cells.

Authors:  K Kai McKinstry; Tara M Strutt; Susan L Swain
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

4.  Targeting the CD134-CD134L interaction using anti-CD134 and/or rhCD134 fusion protein as a possible strategy to prevent lupus nephritis.

Authors:  Yan-bin Zhou; Ren-gao Ye; You-ji Li; Can-mao Xie
Journal:  Rheumatol Int       Date:  2008-09-20       Impact factor: 2.631

5.  Increased CD4+ T cell levels during IL-7 administration of antiretroviral therapy-treated simian immunodeficiency virus-positive macaques are not dependent on strong proliferative responses.

Authors:  Amanda Leone; Mukta Rohankhedkar; Afam Okoye; Alfred Legasse; Michael K Axthelm; Francois Villinger; Michael Piatak; Jeffrey D Lifson; Brigitte Assouline; Michel Morre; Louis J Picker; Donald L Sodora
Journal:  J Immunol       Date:  2010-07-09       Impact factor: 5.422

Review 6.  TNF superfamily: costimulation and clinical applications.

Authors:  Dass S Vinay; Byoung S Kwon
Journal:  Cell Biol Int       Date:  2009-02-20       Impact factor: 3.612

7.  Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor.

Authors:  Aymeric de Parseval; Udayan Chatterji; Peiqing Sun; John H Elder
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

Review 8.  The role of OX40-mediated co-stimulation in T-cell activation and survival.

Authors:  William L Redmond; Carl E Ruby; Andrew D Weinberg
Journal:  Crit Rev Immunol       Date:  2009       Impact factor: 2.214

9.  Monosomy 1p36 uncovers a role for OX40 in survival of activated CD4+ T cells.

Authors:  M M Suhoski; E E Perez; M L Heltzer; A Laney; L G Shaffer; S Saitta; S Nachman; N B Spinner; C H June; J S Orange
Journal:  Clin Immunol       Date:  2008-06-03       Impact factor: 3.969

10.  Pathogenic roles of CD14, galectin-3, and OX40 during experimental cerebral malaria in mice.

Authors:  Miranda S Oakley; Victoria Majam; Babita Mahajan; Noel Gerald; Vivek Anantharaman; Jerrold M Ward; Lawrence J Faucette; Thomas F McCutchan; Hong Zheng; Masaki Terabe; Jay A Berzofsky; L Aravind; Sanjai Kumar
Journal:  PLoS One       Date:  2009-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.